Cite

    Yuko Iwata et al.. “Cancer cachexia causes skeletal muscle damage via transient receptor potential vanilloid 2‐independent mechanisms, unlike muscular dystrophy.” Journal of cachexia, sarcopenia and muscle, vol. 7, no. 3, 2016, pp. 366–376. http://access.bl.uk/ark:/81055/vdc_100035842168.0x000004